Skip to content

Clinical trials

Small Cell Lung Carcinoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Country / region: Australia Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20101
20111
20123
20142
20152
20162
20178
20183
20191
20207
20213
20224
20234
20249
202510
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Recruiting25
Active, not recruiting14
Terminated8
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen9
AbbVie7
Bristol-Myers Squibb5
Merck Sharp & Dohme LLC5
BioNTech SE3
Boehringer Ingelheim3
MacroGenics3
Pfizer3
BeiGene2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma74
Carcinoma, Non-Small-Cell Lung18
Ovarian Neoplasms11
Triple Negative Breast Neoplasms11
Squamous Cell Carcinoma of Head and Neck10
Uterine Cervical Neoplasms9
Breast Neoplasms8
Endometrial Neoplasms8
Lung Neoplasms8
Melanoma8

Trials

Showing 26 to 50 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.